|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||155.70 - 163.99|
|52 Week Range||146.23 - 188.31|
|Beta (5Y Monthly)||0.55|
|PE Ratio (TTM)||20.87|
|Forward Dividend & Yield||3.38 (2.08%)|
|Ex-Dividend Date||May 19, 2022|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for DBOEF
Russian lender Rosbank believes a decision by European clearing house Clearstream to block its correspondent account will not have a significant negative impact on its operations, it said in a statement to a Russian media outlet on Saturday. Clearstream said on Friday UK sanctions on June 29 on Rosbank's majority owner Vladimir Potanin, whose Interros Capital clinched a deal in April to buy the lender from French bank Societe Generale, had forced it into its decision. "Clearstream Banking's cash correspondent bank Rosbank is no longer available to receive income proceeds that may result from securities issued outside of Russia and denominated in roubles," Clearstream said.
European clearing giant Clearstream has halted all requests to convert Russian firms' 'depository receipts' into Moscow-listed shares following the European Union's latest sanctions. Depositary receipts (DRs) are certificates representing shares in a company foreign to where they are traded, which allow investors to trade in overseas stocks. Russian President Vladimir Putin signed a bill in April though requiring all but 15 Russian firms to delist their depositary receipts to reduce potential foreign influence.
German exchange operator Deutsche Boerse raised its full-year targets on Monday as it reported better-than-expected quarterly results thanks to higher trading activity amid Russia's war in Ukraine. Due to the uncertainty on the market, demand for hedging in almost all asset classes rose and boosted trading volumes especially in index derivatives and commodities including energy and gas products, Deutsche Boerse said. "The first quarter of 2022 was considerably above our expectations," Chief Financial Officer Gregor Pottmeyer said in a statement.